C
WVE icon

Covestor’s Wave Life Sciences WVE Stock Holding History

Covestor’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
44
+31
+238% +$206 ﹤0.01% 2883
2026
Q1 		$0 Hold
13
– – ﹤0.01% 2833
2025
Q4 		$0 Hold
13
– – ﹤0.01% 2802
2025
Q3 		$0 Hold
13
– – ﹤0.01% 2848
2025
Q2 		$0 Sell
13
-1
-7% -$7 ﹤0.01% 2817
2025
Q1 		$0 Hold
14
– – ﹤0.01% 2787
2024
Q4 		$0 Buy
+14
New +$187 ﹤0.01% 2805

Other funds holding WVE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Covestor's WVE Position: Q2 2026 in Review

Covestor increased its Wave Life Sciences (WVE) stake by 238% in Q2 2026, buying an estimated $206 and bringing the position to 44 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2883.

Covestor first reported a position in WVE in Q4 2024 and has held it in 7 quarters since. 81 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Covestor held 44 shares of Wave Life Sciences worth $0 as of Q2 2026.
  • Covestor bought 31 Wave Life Sciences shares in Q2 2026, an estimated $206.
  • Wave Life Sciences made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2883 holding.
  • Covestor first reported a position in Wave Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • 81 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.